Squaric acid dibutyl ester

Generic Name
Squaric acid dibutyl ester
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C12H18O4
CAS Number
2892-62-8
Unique Ingredient Identifier
4RTO57VG65
Background

Squaric acid dibutyl ester is under investigation in clinical trial NCT01971385 (Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

First Posted Date
2022-09-10
Last Posted Date
2024-05-23
Lead Sponsor
John Harris
Target Recruit Count
45
Registration Number
NCT05535738
Locations
🇺🇸

University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States

SADBE for Congenital Melanocytic Nevi

First Posted Date
2021-08-11
Last Posted Date
2021-10-28
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
30
Registration Number
NCT04999631

Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)

Phase 1
Completed
Conditions
HSV
Herpes Labialis
Interventions
Drug: Squaric Acid Dibutyl Ester
First Posted Date
2018-09-07
Last Posted Date
2021-11-03
Lead Sponsor
Squarex, LLC
Target Recruit Count
36
Registration Number
NCT03661541
Locations
🇺🇸

Prism Clinical Research, LLC, Saint Paul, Minnesota, United States

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

Phase 2
Terminated
Conditions
HSV
Herpes Labialis
Interventions
Drug: Squaric Acid Dibutyl Ester
First Posted Date
2018-05-11
Last Posted Date
2021-08-06
Lead Sponsor
Squarex, LLC
Target Recruit Count
40
Registration Number
NCT03521479
Locations
🇺🇸

International Research Partners, LLC, Doral, Florida, United States

🇺🇸

Prism Clinical Research, LLC, Saint Paul, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy